Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Isofol Medical AB (publ) | 137,222 | net | 02 Jul 2025 | tx 3+137,222 |
| BioGaia AB | -3,000 | net | 21 May 2019 | tx 1−3,000 |
| Infant Bacterial Therapeutics AB | 1,714 | net | 13 May 2024 | tx 2+1,714 |
| Infant Bacterial Therapeutics IBT | 1,470 | net | 31 Jan 2018 | tx 1+1,470 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Jul 2025 | PURCHASE | Isofol Medical AB (publ) | 7,222 | 9.60 SEK | |
| 27 Jun 2025 | PURCHASE | Isofol Medical AB (publ) | 90,000 | 0.04 SEK | deriv |
| 23 Sept 2024 | PURCHASE | Isofol Medical AB (publ) | 40,000 | 2.56 SEK | |
| 13 May 2024 | PURCHASE | Infant Bacterial Therapeutics AB | 1,000 | 93.41 SEK | |
| 29 Jun 2023 | PURCHASE | Infant Bacterial Therapeutics AB | 714 | 45.00 SEK | first after silence |
| 21 May 2019 | SALE | BioGaia AB | 3,000 | 462.00 SEK | |
| 31 Jan 2018 | PURCHASE | Infant Bacterial Therapeutics IBT | 1,470 | 95.00 SEK |
1 purchase reported after at least 12 months of silence — most recent on 29 Jun 2023.